Inhibition of mTORs Catalytic Site by PKI-587 is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease
Freitag, Helma, Christen, Friederike, Lewens, Florentine, Grass, Irina, Briest, Franziska, Iwaszkiewicz, Sara, Siegmund, Britta, Grabowski, PatriciaLanguage:
english
Journal:
Neuroendocrinology
DOI:
10.1159/000448843
Date:
August, 2016
File:
PDF, 916 KB
english, 2016